17940018	11363	Zhang D	Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2007	78
20203611	11363	Hirschey MD	SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation.	Nature	2010	391
24121500	11363	Bharathi SS	Sirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site.	The Journal of biological chemistry	2013	27
15565109	11430	Lee JS	Application of comparative functional genomics to identify best-fit mouse models to study human cancer.	Nature genetics	2004	143
23349482	11430	Chan SM	Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.	Diabetes	2013	28
23555678	11430	Park DY	Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity.	PloS one	2013	37
11479628	11450	Berg AH	The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.	Nature medicine	2001	408
11748271	11450	Combs TP	Endogenous glucose production is inhibited by the adipose-derived protein Acrp30.	The Journal of clinical investigation	2001	129
12496257	11450	Pajvani UB	Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity.	The Journal of biological chemistry	2003	203
12802337	11450	Yamauchi T	Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.	Nature	2003	503
14724832	11450	Kamada Y	Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin.	Gastroenterology	2003	79
15210937	11450	Hug C	T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin.	Proceedings of the National Academy of Sciences of the United States of America	2004	185
15599400	11450	Furukawa S	Increased oxidative stress in obesity and its impact on metabolic syndrome.	The Journal of clinical investigation	2004	783
15897298	11450	Kadowaki T	Adiponectin and adiponectin receptors.	Endocrine reviews	2005	442
16306372	11450	Park SY	Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice.	Diabetes	2005	94
16374858	11450	Schattenberg JM	JNK1 but not JNK2 promotes the development of steatohepatitis in mice.	Hepatology	2006	109
16374859	11450	Ding X	Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.	Hepatology	2006	87
16567517	11450	Zvonic S	Characterization of peripheral circadian clocks in adipose tissues.	Diabetes	2006	131
17476695	11450	Yamaguchi K	Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.	Hepatology	2007	180
17569885	11450	Itoh M	Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects.	Arteriosclerosis, thrombosis, and vascular biology	2007	59
17717599	11450	Kim JY	Obesity-associated improvements in metabolic profile through expansion of adipose tissue.	The Journal of clinical investigation	2007	371
18326786	11450	Membrez M	Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.	FASEB journal 	2008	104
18403477	11450	Weisberg SP	Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity.	Endocrinology	2008	53
18755807	11450	Ajmo JM	Resveratrol alleviates alcoholic fatty liver in mice.	American journal of physiology. Gastrointestinal and liver physiology	2008	101
19211925	11450	González-Périz A	Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.	FASEB journal 	2009	136
20007851	11450	Shen Z	Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.	American journal of physiology. Gastrointestinal and liver physiology	2010	56
20064576	11450	Cho AS	Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice.	Food and chemical toxicology 	2010	53
20065609	11450	Libby P	Inflammation in atherosclerosis: transition from theory to practice.	Circulation journal 	2010	140
20858684	11450	Duval C	Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice.	Diabetes	2010	51
21256905	11450	Xu J	Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK.	Journal of hepatology	2011	45
21462320	11450	Kobori M	Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice.	Molecular nutrition and food research	2011	41
21737828	11450	Reinke C	Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes.	Journal of applied physiology	2011	50
22457829	11450	Lam YY	Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice.	PloS one	2012	74
22863618	11450	Schipper HS	Natural killer T cells in adipose tissue prevent insulin resistance.	The Journal of clinical investigation	2012	48
23236485	11450	Ables GP	Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density.	PloS one	2012	31
23562077	11450	Mansuy-Aubert V	Imbalance between neutrophil elastase and its inhibitor α1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure.	Cell metabolism	2013	31
23832548	11450	Wan J	M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.	Hepatology	2014	63
25794851	11450	Lin Z	Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.	Circulation	2015	16
25830704	11450	Liu X	Brown Adipose Tissue Transplantation Reverses Obesity in Ob/Ob Mice.	Endocrinology	2015	19
26581599	11450	Gavin KM	De novo generation of adipocytes from circulating progenitor cells in mouse and human adipose tissue.	FASEB journal 	2016	10
15389867	11475	Magness ST	A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations.	Hepatology	2004	71
19085956	11475	Asahina K	Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development.	Hepatology	2009	55
19296469	11475	Van Hul NK	Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury.	Hepatology	2009	49
21316604	11475	Quante M	Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.	Cancer cell	2011	211
21520179	11475	Chu AS	Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis.	Hepatology	2011	63
21798245	11475	Sekiya Y	Suppression of hepatic stellate cell activation by microRNA-29b.	Biochemical and biophysical research communications	2011	46
24173292	11475	Swiderska-Syn M	Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy.	Gut	2014	28
25356754	11475	Wang J	microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway.	Oncotarget	2015	25
26494449	11475	Sun C	Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-β/Smad signaling.	Journal of applied physiology	2016	14
15644454	11520	Schadinger SE	PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.	American journal of physiology. Endocrinology and metabolism	2005	92
16428458	11520	Chang BH	Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein.	Molecular and cellular biology	2006	101
18487449	11520	Bell M	Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance.	Diabetes	2008	56
22210478	11520	Tomaru U	Decreased proteasomal activity causes age-related phenotypes and promotes the development of metabolic abnormalities.	The American journal of pathology	2012	31
23402988	11520	McManaman JL	Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease.	Journal of lipid research	2013	40
10363983	11545	Adams J	Proteasome inhibitors: a novel class of potent and effective antitumor agents.	Cancer research	1999	234
20832105	11545	Asher G	Poly(ADP-ribose) polymerase 1 participates in the phase entrainment of circadian clocks to feeding.	Cell	2010	89
24089324	11545	Mukhopadhyay P	Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis.	Hepatology	2014	27
24375466	11545	Huang H	Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: a role for intracellular high-mobility group box 1 in cellular protection.	Hepatology	2014	36
15959514	11576	Lee CS	The initiation of liver development is dependent on Foxa transcription factors.	Nature	2005	168
17086172	11576	Gouon-Evans V	BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm.	Nature biotechnology	2006	115
19150350	11576	Yamashita T	EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.	Gastroenterology	2009	274
22974708	11576	Villanueva A	Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice.	Gastroenterology	2012	62
25346390	11576	Uriarte I	Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.	International journal of cancer	2015	16
1549603	11622	Zhang Y	A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure.	Proceedings of the National Academy of Sciences of the United States of America	1992	235
7732381	11622	Fernandez-Salguero P	Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor.	Science	1995	196
8692887	11622	Schmidt JV	Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development.	Proceedings of the National Academy of Sciences of the United States of America	1996	202
8806883	11622	Fernandez-Salguero PM	Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity.	Toxicology and applied pharmacology	1996	121
10639156	11622	Shimizu Y	Benzoapyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor.	Proceedings of the National Academy of Sciences of the United States of America	2000	94
15028720	11622	Nebert DW	Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer.	The Journal of biological chemistry	2004	199
15790560	11622	Miao W	Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes.	The Journal of biological chemistry	2005	80
15833929	11622	Maher JM	Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver.	Drug metabolism and disposition	2005	70
16214954	11622	Tijet N	Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries.	Molecular pharmacology	2006	88
16377763	11622	Uno S	Oral benzoapyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate.	Molecular pharmacology	2006	62
19474220	11622	Yeager RL	Introducing the "TCDD-inducible AhR-Nrf2 gene battery".	Toxicological sciences 	2009	61
19996281	11622	Fan Y	The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis.	Cancer research	2010	49
20303349	11622	Lee JH	A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis.	Gastroenterology	2010	43
23099484	11622	Baker NA	Coplanar polychlorinated biphenyls impair glucose homeostasis in lean C57BL/6 mice and mitigate beneficial effects of weight loss on glucose homeostasis in obese mice.	Environmental health perspectives	2013	26
23771949	11622	Safe S	Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.	Toxicological sciences 	2013	45
24154488	11622	Pierre S	Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin.	Toxicological sciences 	2014	23
24930766	11622	Bessede A	Aryl hydrocarbon receptor control of a disease tolerance defence pathway.	Nature	2014	81
25614121	11622	Lu P	Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21.	Hepatology	2015	16
25768209	11622	Zhang L	Persistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation.	Environmental health perspectives	2015	24
12791994	11651	Du K	TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver.	Science	2003	234
15509553	11651	Nakatani Y	Involvement of endoplasmic reticulum stress in insulin resistance and diabetes.	The Journal of biological chemistry	2005	123
17891174	11651	Ma S	CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.	Oncogene	2008	198
18249175	11651	Izumiya Y	Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice.	Cell metabolism	2008	118
19138937	11651	Moore T	Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues.	Cancer prevention research	2008	52
20615072	11651	Cheng Z	Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models.	Antioxidants and redox signaling	2011	52
20843817	11651	Choi SS	Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway.	The Journal of biological chemistry	2010	41
21441927	11651	Jordan SD	Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism.	Nature cell biology	2011	105
21723501	11651	Yecies JL	Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.	Cell metabolism	2011	115
21744257	11651	Ogunwobi OO	Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways.	Clinical and experimental metastasis	2011	39
21965330	11651	Wang RH	Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.	The Journal of clinical investigation	2011	86
21993994	11651	Ho C	AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.	Hepatology	2012	49
22004992	11651	Jitrapakdee S	Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis.	The international journal of biochemistry and cell biology	2012	31
22322096	11651	Stokes MP	PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS.	Molecular and cellular proteomics 	2012	31
22344295	11651	Lu M	Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1.	Nature medicine	2012	75
22773877	11651	Yuan M	Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.	The Journal of biological chemistry	2012	43
22797301	11651	Fan B	Cholangiocarcinomas can originate from hepatocytes in mice.	The Journal of clinical investigation	2012	79
23342074	11651	Yuzefovych LV	Mitochondrial DNA damage and dysfunction, and oxidative stress are associated with endoplasmic reticulum stress, protein degradation and apoptosis in high fat diet-induced insulin resistance mice.	PloS one	2013	40
24067903	11651	Shukla S	Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.	Carcinogenesis	2014	21
24825302	11651	Chang RM	MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.	Hepatology	2014	31
25617127	11651	Chen CL	Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation.	Biomaterials	2015	35
26100075	11651	Braccini L	PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling.	Nature communications	2015	15
26476289	11651	Li L	Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.	Journal of hepatology	2016	11
26589417	11651	Li WF	Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.	Tumour biology 	2016	11
26848154	11651	Correia-Melo C	Mitochondria are required for pro-ageing features of the senescent phenotype.	The EMBO journal	2016	29
26857837	11651	Hu J	Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.	Scientific reports	2016	11
27153497	11651	Masri S	Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis.	Cell	2016	17
3690666	11657	Lichtsteiner S	The interplay of DNA-binding proteins on the promoter of the mouse albumin gene.	Cell	1987	179
3779841	11657	Gorski K	Tissue-specific in vitro transcription from the mouse albumin promoter.	Cell	1986	336
11479625	11657	Mercer DF	Hepatitis C virus replication in mice with chimeric human livers.	Nature medicine	2001	220
19242562	11657	Joyce MA	HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice.	PLoS pathogens	2009	59
20564331	11657	Ding W	Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion.	Hepatology	2010	48
22689379	11657	Srivastava J	Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model.	Hepatology	2012	34
25363772	11657	Barzel A	Promoterless gene targeting without nucleases ameliorates haemophilia B in mice.	Nature	2015	39
11320206	11720	Lu SC	Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation.	Proceedings of the National Academy of Sciences of the United States of America	2001	108
23073625	11720	Lu SC	S-adenosylmethionine in liver health, injury, and cancer.	Physiological reviews	2012	65
16054052	11770	Maeda K	Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes.	Cell metabolism	2005	118
17554340	11770	Furuhashi M	Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.	Nature	2007	153
18551191	11770	Furuhashi M	Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice.	The Journal of clinical investigation	2008	82
23991091	11770	Miller AM	MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice.	PloS one	2013	32
16365039	11793	Kamimoto T	Intracellular inclusions containing mutant alpha1-antitrypsin Z are propagated in the absence of autophagic activity.	The Journal of biological chemistry	2006	82
18073215	11793	Wang Y	Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus.	The Journal of biological chemistry	2008	56
18188005	11793	Miller BC	The autophagy gene ATG5 plays an essential role in B lymphocyte development.	Autophagy	2008	110
18337468	11793	Kaushik S	Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy.	Molecular biology of the cell	2008	91
20519119	11793	Yang L	Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance.	Cell metabolism	2010	249
21041446	11793	Riley BE	Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection.	The Journal of cell biology	2010	64
21498569	11793	Takamura A	Autophagy-deficient mice develop multiple liver tumors.	Genes and development	2011	258
22240484	11793	Hernández-Gea V	Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues.	Gastroenterology	2012	95
22491424	11793	Ni HM	Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury.	Toxicological sciences 	2012	43
22684107	11793	Sinha RA	Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy.	The Journal of clinical investigation	2012	38
23181220	11793	Kongara S	The interplay between autophagy and ROS in tumorigenesis.	Frontiers in oncology	2012	35
23912709	11793	He Z	p73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene.	Cell death and differentiation	2013	25
24815875	11793	Ni HM	Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy.	Journal of hepatology	2014	28
25526090	11793	Tian Y	Autophagy inhibits oxidative stress and tumor suppressors to exert its dual effect on hepatocarcinogenesis.	Cell death and differentiation	2015	18
25550510	11793	López-Vicario C	Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.	Proceedings of the National Academy of Sciences of the United States of America	2015	16
25650776	11793	Liu K	Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization.	Autophagy	2015	35
26061908	11793	Lodder J	Macrophage autophagy protects against liver fibrosis in mice.	Autophagy	2015	16
26325539	11793	Ilyas G	Macrophage autophagy limits acute toxic liver injury in mice through down regulation of interleukin-1β.	Journal of hepatology	2016	10
12900335	11806	Zhang Y	Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo.	Circulation	2003	108
25993337	11806	Kasumov T	Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.	PloS one	2015	16
9069289	11816	Suzuki H	A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection.	Nature	1997	214
9169506	11816	Gupta S	IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.	The Journal of clinical investigation	1997	160
9261096	11816	Ji Y	Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux.	The Journal of biological chemistry	1997	108
10430941	11816	Trigatti B	Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.	Proceedings of the National Academy of Sciences of the United States of America	1999	112
12097330	11816	Grefhorst A	Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles.	The Journal of biological chemistry	2002	108
15087308	11816	Meir KS	Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress.	Arteriosclerosis, thrombosis, and vascular biology	2004	87
15590644	11816	Hojjati MR	Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.	The Journal of biological chemistry	2005	66
16462940	11816	Wang S	Genetic and genomic analysis of a fat mass trait with complex inheritance reveals marked sex specificity.	PLoS genetics	2006	78
16961926	11816	Peters A	Translocation and potential neurological effects of fine and ultrafine particles a critical update.	Particle and fibre toxicology	2006	63
17657314	11816	Bradley MN	Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE.	The Journal of clinical investigation	2007	83
18202315	11816	Araujo JA	Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress.	Circulation research	2008	121
18549781	11816	Jiang Q	ApoE promotes the proteolytic degradation of Abeta.	Neuron	2008	240
19015167	11816	States JC	Arsenic and cardiovascular disease.	Toxicological sciences 	2009	71
20068138	11816	Arakawa M	Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.	Diabetes	2010	96
20460915	11816	Trauner M	Bile acids as regulators of hepatic lipid and glucose metabolism.	Digestive diseases	2010	58
20461061	11816	Akinc A	Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.	Molecular therapy 	2010	109
20947826	11816	Barajas B	NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection.	Arteriosclerosis, thrombosis, and vascular biology	2011	35
21041949	11816	Feig JE	LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression.	The Journal of clinical investigation	2010	47
21699799	11816	Long G	Mouse hepatic cells support assembly of infectious hepatitis C virus particles.	Gastroenterology	2011	46
22210379	11816	Mercer JR	The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.	Free radical biology and medicine	2012	30
22323736	11816	Cramer PE	ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.	Science	2012	271
22836247	11816	Mandrekar-Colucci S	Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease.	The Journal of neuroscience 	2012	81
23183176	11816	Panjwani N	GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice.	Endocrinology	2013	52
25754609	11816	Berbée JF	Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.	Nature communications	2015	23
11779462	11865	Lee C	Posttranslational mechanisms regulate the mammalian circadian clock.	Cell	2001	308
16109848	11865	Cardone L	Circadian clock control by SUMOylation of BMAL1.	Science	2005	95
16675400	11865	Debruyne JP	A clock shock: mouse CLOCK is not required for circadian oscillator function.	Neuron	2006	126
18075593	11865	Hirayama J	CLOCK-mediated acetylation of BMAL1 controls circadian function.	Nature	2007	139
18086663	11865	Gréchez-Cassiau A	The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation.	The Journal of biological chemistry	2008	78
18662547	11865	Nakahata Y	The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control.	Cell	2008	367
18779586	11865	Lamia KA	Physiological significance of a peripheral tissue circadian clock.	Proceedings of the National Academy of Sciences of the United States of America	2008	274
19917250	11865	Chen R	Rhythmic PER abundance defines a critical nodal point for negative feedback within the circadian clock mechanism.	Molecular cell	2009	67
21364973	11865	Rey G	Genome-wide and phase-specific DNA-binding rhythms of BMAL1 control circadian output functions in mouse liver.	PLoS biology	2011	142
21966465	11865	Shimba S	Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation.	PloS one	2011	57
22593546	11865	Sherman H	Timed high-fat diet resets circadian metabolism and prevents obesity.	FASEB journal 	2012	47
23150795	11865	Menet JS	Nascent-Seq reveals novel features of mouse circadian transcriptional regulation.	eLife	2012	89
23395176	11865	Li MD	O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitination.	Cell metabolism	2013	35
26365180	11865	Jacobi D	Hepatic Bmal1 Regulates Rhythmic Mitochondrial Dynamics and Promotes Metabolic Fitness.	Cell metabolism	2015	19
26542580	11865	Perelis M	Pancreatic β cell enhancers regulate rhythmic transcription of genes controlling insulin secretion.	Science	2015	32
26554015	11865	Atger F	Circadian and feeding rhythms differentially affect rhythmic mRNA transcription and translation in mouse liver.	Proceedings of the National Academy of Sciences of the United States of America	2015	23
26843191	11865	Yang G	Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival.	Science translational medicine	2016	18
16505490	12028	Malhi H	Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis.	The Journal of biological chemistry	2006	163
16645094	12028	Hetz C	Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha.	Science	2006	185
16831600	12028	Gunawan BK	c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity.	Gastroenterology	2006	133
17906064	12028	Bajt ML	Mitochondrial bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity.	The Journal of pharmacology and experimental therapeutics	2008	55
19053047	12028	Singh R	Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance.	Hepatology	2009	71
23531302	12028	Nasir GA	Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice.	Journal of translational medicine	2013	30
25264893	12028	Wang C	N-acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway.	PloS one	2014	22
18539898	12161	Kautz L	Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver.	Blood	2008	125
19252488	12161	Meynard D	Lack of the bone morphogenetic protein BMP6 induces massive iron overload.	Nature genetics	2009	174
19591830	12161	Corradini E	Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis.	Gastroenterology	2009	45
21480335	12161	Ramos E	Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice.	Hepatology	2011	62
21488083	12161	Corradini E	Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice.	Hepatology	2011	45
23907767	12161	Latour C	Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin.	Hepatology	2014	27
27864295	12161	Canali S	Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice.	Blood	2017	6
9742082	12355	Honkakoski P	The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene.	Molecular and cellular biology	1998	148
10454578	12355	Kawamoto T	Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene.	Molecular and cellular biology	1999	119
11057673	12355	Wei P	The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism.	Nature	2000	148
11706036	12355	Kast HR	Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.	The Journal of biological chemistry	2002	123
11752199	12355	Ueda A	Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital.	Molecular pharmacology	2002	103
12181440	12355	Maglich JM	Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification.	Molecular pharmacology	2002	135
12514743	12355	Tirona RG	The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4.	Nature medicine	2003	77
12923173	12355	Guo GL	Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.	The Journal of biological chemistry	2003	79
15492232	12355	Yamamoto Y	The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice.	Cancer research	2004	80
15831521	12355	Huang W	Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor.	Molecular endocrinology	2005	75
19617349	12355	Gao J	The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity.	The Journal of biological chemistry	2009	69
19850873	12355	Dong B	Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease.	Proceedings of the National Academy of Sciences of the United States of America	2009	73
8720919	12359	Lenzen S	Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues.	Free radical biology and medicine	1996	174
14615275	12359	Navarro A	Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer.	American journal of physiology. Regulatory, integrative and comparative physiology	2004	70
15178682	12359	Ho YS	Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury.	The Journal of biological chemistry	2004	75
17034877	12359	Schrader M	Peroxisomes and oxidative stress.	Biochimica et biophysica acta	2006	113
19164858	12362	Imaeda AB	Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome.	The Journal of clinical investigation	2009	175
21217695	12362	Vandanmagsar B	The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance.	Nature medicine	2011	439
21488066	12362	Csak T	Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.	Hepatology	2011	104
21876127	12362	Stienstra R	Inflammasome is a central player in the induction of obesity and insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2011	149
22234969	12362	Yan W	High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.	Hepatology	2012	56
22411067	12362	Dixon LJ	Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.	Laboratory investigation; a journal of technical methods and pathology	2012	33
22945633	12362	Petrasek J	IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice.	The Journal of clinical investigation	2012	127
22987396	12362	Miura K	Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice.	Hepatology	2013	46
23408710	12362	Kamo N	ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury.	Hepatology	2013	28
23409132	12362	Dixon LJ	Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis.	PloS one	2013	29
23904166	12362	Huang H	Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury.	Journal of immunology	2013	28
25327779	12362	Kim HY	Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion.	The FEBS journal	2015	16
26008898	12362	Kim ML	Aberrant actin depolymerization triggers the pyrin inflammasome and autoinflammatory disease that is dependent on IL-18, not IL-1β.	The Journal of experimental medicine	2015	16
11452314	12367	Li LY	Endonuclease G is an apoptotic DNase when released from mitochondria.	Nature	2001	292
12011492	12367	Gujral JS	Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis?	Toxicological sciences 	2002	91
15254240	12367	Erster S	In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation.	Molecular and cellular biology	2004	98
15486922	12367	Kon K	Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes.	Hepatology	2004	133
16201016	12367	Zamarin D	Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1.	PLoS pathogens	2005	113
19676126	12367	Witek RP	Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.	Hepatology	2009	61
24750664	12367	Barreyro FJ	The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.	Liver international 	2015	23
26632633	12367	Verma VK	Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles.	Journal of hepatology	2016	15
27668795	12367	Zanganeh S	Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.	Nature nanotechnology	2016	19
9671767	12387	de La Coste A	Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.	Proceedings of the National Academy of Sciences of the United States of America	1998	212
15131783	12387	Ireland H	Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin.	Gastroenterology	2004	103
16740478	12387	Benhamouche S	Apc tumor suppressor gene is the "zonation-keeper" of mouse liver.	Developmental cell	2006	89
17101329	12387	Tan X	Conditional deletion of beta-catenin reveals its role in liver growth and regeneration.	Gastroenterology	2006	97
17929301	12387	Apte U	Wnt/beta-catenin signaling mediates oval cell response in rodents.	Hepatology	2008	56
18068630	12387	Zhao C	Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo.	Cancer cell	2007	184
18393386	12387	Tan X	Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development.	Hepatology	2008	60
19303855	12387	Goessling W	Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration.	Cell	2009	215
19718050	12387	van Zijl F	Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge.	Oncogene	2009	51
19850960	12387	Fox JG	Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens.	Gut	2010	49
20432254	12387	Nejak-Bowen KN	Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin.	Hepatology	2010	52
22811581	12387	Lachenmayer A	Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.	Clinical cancer research 	2012	52
25964079	12387	Yuan SX	Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1.	Hepatology	2016	36
26908355	12387	Sarris ME	Smyd3 Is a Transcriptional Potentiator of Multiple Cancer-Promoting Genes and Required for Liver and Colon Cancer Development.	Cancer cell	2016	12
7878023	12411	Watanabe M	Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.	Proceedings of the National Academy of Sciences of the United States of America	1995	145
20566639	12411	Ishii I	Cystathionine gamma-Lyase-deficient mice require dietary cysteine to protect against acute lethal myopathy and oxidative injury.	The Journal of biological chemistry	2010	58
10728791	12443	Fausto N	Liver regeneration.	Journal of hepatology	2000	211
18537191	12443	Zhang Y	Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation.	Hepatology	2008	54
18981289	12443	Maran RR	Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development.	The Journal of pharmacology and experimental therapeutics	2009	57
19874425	12443	Rattan R	Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner.	Journal of cellular and molecular medicine	2011	56
22326957	12443	Ng R	A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration.	The Journal of clinical investigation	2012	47
24700412	12443	Yang J	β-catenin signaling in murine liver zonation and regeneration: a Wnt-Wnt situation!	Hepatology	2014	22
24870244	12443	Lee Y	Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression.	Nature	2014	23
24954587	12443	Degirolamo C	Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.	Hepatology	2015	16
26806818	12443	Lua I	Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers.	Journal of hepatology	2016	16
11018074	12475	Kono H	NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease.	The Journal of clinical investigation	2000	120
14979920	12475	Stein T	Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3.	Breast cancer research 	2004	111
17023554	12475	Brun P	Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.	American journal of physiology. Gastrointestinal and liver physiology	2007	162
17456850	12475	Cani PD	Metabolic endotoxemia initiates obesity and insulin resistance.	Diabetes	2007	733
19115316	12475	Velayudham A	VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.	Hepatology	2009	59
22768838	12475	Imajo K	Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.	Cell metabolism	2012	51
9133426	12479	Mendiratta SK	CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4.	Immunity	1997	155
11927628	12479	Pellicci DG	A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.	The Journal of experimental medicine	2002	103
12093876	12479	Crowe NY	A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.	The Journal of experimental medicine	2002	99
15791257	12479	Kinjo Y	Recognition of bacterial glycosphingolipids by natural killer T cells.	Nature	2005	302
16138194	12479	Parekh VV	Glycolipid antigen induces long-term natural killer T cell anergy in mice.	The Journal of clinical investigation	2005	136
17256743	12479	Erhardt A	IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice.	Hepatology	2007	59
17641782	12479	Halder RC	Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease.	The Journal of clinical investigation	2007	84
19199937	12479	Wu L	Natural killer T cells and autoimmune disease.	Current molecular medicine	2009	53
20512988	12479	Syn WK	Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.	Hepatology	2010	63
21389252	12479	Dieudé M	Cardiolipin binds to CD1d and stimulates CD1d-restricted γδ T cells in the normal murine repertoire.	Journal of immunology	2011	35
21674035	12479	Mantell BS	Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity.	PloS one	2011	38
21921158	12479	Wong CH	Functional innervation of hepatic iNKT cells is immunosuppressive following stroke.	Science	2011	83
22427237	12479	Syn WK	NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease.	Gut	2012	51
22645141	12479	Ji Y	Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4.	The Journal of biological chemistry	2012	41
24703850	12479	Miller JL	Interferon-mediated innate immune responses against malaria parasite liver stages.	Cell reports	2014	28
10613752	12490	Theise ND	Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation.	Hepatology	2000	140
12163453	12490	Iwano M	Evidence that fibroblasts derive from epithelium during tissue fibrosis.	The Journal of clinical investigation	2002	507
16857736	12490	Chute JP	Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2006	126
17078891	12490	Berges BK	HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.	Retrovirology	2006	72
19412179	12490	Mátés L	Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates.	Nature genetics	2009	189
19524633	12490	Lepus CM	Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice.	Human immunology	2009	48
21799532	12490	Denton PW	Humanized mouse models of HIV infection.	AIDS reviews	2011	58
24266938	12490	Xiao J	Telocytes in liver: electron microscopic and immunofluorescent evidence.	Journal of cellular and molecular medicine	2013	36
12021254	12491	Hajri T	Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice.	The Journal of clinical investigation	2002	84
16556603	12491	Zhou J	A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway.	The Journal of biological chemistry	2006	96
17728375	12491	Koonen DP	Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity.	Diabetes	2007	82
18242221	12491	Zhou J	Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.	Gastroenterology	2008	118
21507897	12491	Morán-Salvador E	Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts.	FASEB journal 	2011	80
23371517	12491	Ma Y	Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance.	Pharmaceutical research	2013	27
26650570	12491	Wilson CG	Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.	Endocrinology	2016	12
26853749	12491	Schlein C	FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues.	Cell metabolism	2016	15
2792758	12606	Birkenmeier EH	Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein.	Genes and development	1989	169
7652557	12606	Wang ND	Impaired energy homeostasis in C/EBP alpha knockout mice.	Science	1995	203
9012825	12606	Zhang DE	Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	1997	217
15589173	12606	Zhang P	Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha.	Immunity	2004	146
15716955	12606	Conboy IM	Rejuvenation of aged progenitor cells by exposure to a young systemic environment.	Nature	2005	509
18166355	12606	Nishina S	Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription.	Gastroenterology	2008	59
19287494	12606	Bozek K	Regulation of clock-controlled genes in mammals.	PloS one	2009	68
20554909	12606	Laing S	Airborne particulate matter selectively activates endoplasmic reticulum stress response in the lung and liver tissues.	American journal of physiology. Cell physiology	2010	40
23178710	12606	Li J	miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression.	Journal of hepatology	2013	32
12228220	12702	Rui L	SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2.	The Journal of biological chemistry	2002	211
12438448	12702	Hong F	Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.	The Journal of clinical investigation	2002	83
12560330	12702	Senn JJ	Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.	The Journal of biological chemistry	2003	104
12754505	12702	Croker BA	SOCS3 negatively regulates IL-6 signaling in vivo.	Nature immunology	2003	217
15240880	12702	Ueki K	Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse.	Proceedings of the National Academy of Sciences of the United States of America	2004	79
16890540	12702	Kievit P	Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells.	Cell metabolism	2006	76
18158318	12702	Riehle KJ	Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3.	The Journal of experimental medicine	2008	54
19435851	12702	Yang G	Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome.	American journal of physiology. Endocrinology and metabolism	2009	84
19564419	12702	Sarasin-Filipowicz M	Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43.	Molecular and cellular biology	2009	56
20098690	12702	Kleemann R	Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance.	PloS one	2010	56
20660075	12702	Moschen AR	Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression.	Gut	2010	44
22234172	12702	Zhong W	Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis.	The American journal of pathology	2012	40
22961088	12702	Jorgensen SB	Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity.	Diabetes	2013	34
12483227	12753	Etchegaray JP	Rhythmic histone acetylation underlies transcription in the mammalian circadian clock.	Nature	2003	175
12865428	12753	Oishi K	Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes.	The Journal of biological chemistry	2003	86
15500444	12753	Oishi K	CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor alpha (PPARalpha) in mice.	The Biochemical journal	2005	66
15520194	12753	Filipski E	Effects of chronic jet lag on tumor progression in mice.	Cancer research	2004	72
15845877	12753	Turek FW	Obesity and metabolic syndrome in circadian Clock mutant mice.	Science	2005	573
17360649	12753	Miller BH	Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation.	Proceedings of the National Academy of Sciences of the United States of America	2007	144
20674862	12753	Pan X	Diurnal regulation of MTP and plasma triglyceride by CLOCK is mediated by SHP.	Cell metabolism	2010	54
23825629	12753	Summa KC	Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation.	PloS one	2013	35
8757135	12767	Nagasawa T	Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1.	Nature	1996	441
9634238	12767	Zou YR	Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development.	Nature	1998	512
9689100	12767	Ma Q	Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	1998	363
10229189	12767	Ma Q	The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment.	Immunity	1999	156
15647826	12767	Sun YX	Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.	Journal of bone and mineral research 	2005	101
19264920	12767	Eash KJ	CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions.	Blood	2009	58
23706740	12767	Casanova-Acebes M	Rhythmic modulation of the hematopoietic niche through neutrophil clearance.	Cell	2013	59
23813475	12767	Bertran E	Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells.	Hepatology	2013	27
24242874	12767	Chen Y	Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice.	Hepatology	2014	26
24256728	12767	Ding BS	Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.	Nature	2014	88
25529917	12767	Chen Y	CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.	Hepatology	2015	29
9342361	12772	Kuziel WA	Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2.	Proceedings of the National Academy of Sciences of the United States of America	1997	182
16341265	12772	Weisberg SP	CCR2 modulates inflammatory and metabolic effects of high-fat feeding.	The Journal of clinical investigation	2006	425
18453605	12772	Jia T	Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection.	Journal of immunology	2008	83
18713872	12772	Holt MP	Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury.	Journal of leukocyte biology	2008	82
19228962	12772	D'Mello C	Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation.	The Journal of neuroscience 	2009	127
19359521	12772	Mitchell C	Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice.	The American journal of pathology	2009	47
20103702	12772	Obstfeld AE	C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.	Diabetes	2010	65
20234092	12772	Si Y	CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice.	The Journal of clinical investigation	2010	63
20714353	12772	Bosschaerts T	Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling.	PLoS pathogens	2010	60
21813474	12772	Baeck C	Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.	Gut	2012	83
21826694	12772	Mandrekar P	An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.	Hepatology	2011	58
22190646	12772	Oh DY	Increased macrophage migration into adipose tissue in obese mice.	Diabetes	2012	83
22442158	12772	Miura K	Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.	American journal of physiology. Gastrointestinal and liver physiology	2012	79
23081697	12772	Zhao L	Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis.	Hepatology	2013	38
23091461	12772	Zimmermann HW	Functional role of monocytes and macrophages for the inflammatory response in acute liver injury.	Frontiers in physiology	2012	60
23653148	12772	Sanford DE	Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.	Clinical cancer research 	2013	81
23686489	12772	Lança T	Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.	Journal of immunology	2013	37
24890723	12772	Zigmond E	Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury.	Journal of immunology	2014	41
25315009	12772	Morinaga H	Characterization of distinct subpopulations of hepatic macrophages in HFD/obese mice.	Diabetes	2015	15
25800956	12772	Dal-Secco D	A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury.	The Journal of experimental medicine	2015	39
26452628	12772	Li X	Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.	Gut	2017	24
10772651	13106	Leclercq IA	CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.	The Journal of clinical investigation	2000	125
11296694	13106	Chitturi S	Etiopathogenesis of nonalcoholic steatohepatitis.	Seminars in liver disease	2001	89
11812920	13106	Jaeschke H	Mechanisms of hepatotoxicity.	Toxicological sciences 	2002	183
15603755	13106	Gonzalez FJ	Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1.	Mutation research	2005	71
18078827	13106	Lu Y	CYP2E1 and oxidative liver injury by alcohol.	Free radical biology and medicine	2008	146
18393316	13106	Lu Y	Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice.	Hepatology	2008	75
18752470	13106	Mantena SK	High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo.	The Biochemical journal	2009	61
19133650	13106	Roychowdhury S	An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice.	Hepatology	2009	48
20692331	13106	Lu Y	Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice.	Free radical biology and medicine	2010	52
22668639	13106	Abdelmegeed MA	Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis.	Journal of hepatology	2012	63
23319235	13106	Roychowdhury S	Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury.	Hepatology	2013	58
24064383	13106	Abdelmegeed MA	CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.	Free radical biology and medicine	2013	37
10935643	13112	Xie W	Humanized xenobiotic response in mice expressing nuclear receptor SXR.	Nature	2000	141
11260270	13122	Hara R	Restricted feeding entrains liver clock without participation of the suprachiasmatic nucleus.	Genes to cells 	2001	101
11279518	13122	Shih DQ	Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism.	Nature genetics	2001	87
17627937	13122	Lin BC	Liver-specific activities of FGF19 require Klotho beta.	The Journal of biological chemistry	2007	58
20623580	13122	Li T	Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice.	Hepatology	2010	49
20671298	13122	Zhang Y	Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice.	Journal of lipid research	2010	42
21319191	13122	Li T	Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.	Hepatology	2011	42
11481335	13350	Cases S	Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members.	The Journal of biological chemistry	2001	153
17618857	13350	Monetti M	Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.	Cell metabolism	2007	166
9113979	13819	Ema M	A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development.	Proceedings of the National Academy of Sciences of the United States of America	1997	216
14608355	13819	Scortegagna M	Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice.	Nature genetics	2003	145
17404621	13819	Rankin EB	Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo.	The Journal of clinical investigation	2007	159
18490920	13819	Rankin EB	Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice.	Oncogene	2008	52
19352007	13819	Mastrogiannaki M	HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice.	The Journal of clinical investigation	2009	121
19498162	13819	Dioum EM	Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1.	Science	2009	148
20628150	13819	Kapitsinou PP	Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.	Blood	2010	75
22207682	13819	Mastrogiannaki M	Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis.	Haematologica	2012	34
8260699	13856	Wang GL	Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction.	Blood	1993	133
15456912	13856	Brines M	Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.	Proceedings of the National Academy of Sciences of the United States of America	2004	151
16373502	13856	Safran M	Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production.	Proceedings of the National Academy of Sciences of the United States of America	2006	86
16497104	13856	Vokurka M	Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis.	Physiological research	2006	66
17981124	13856	Cheng J	SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia.	Cell	2007	158
18202227	13856	Obara N	Repression via the GATA box is essential for tissue-specific erythropoietin gene expression.	Blood	2008	50
18347089	13856	Hennighausen L	Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B.	Genes and development	2008	117
25193872	13856	Kautz L	Erythroferrone contributes to recovery from anemia of inflammation.	Blood	2014	20
16522813	14069	Jiang H	Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs.	Blood	2006	71
19139414	14069	Xu D	Phenotypic correction of murine hemophilia A using an iPS cell-based therapy.	Proceedings of the National Academy of Sciences of the United States of America	2009	80
22655063	14069	Sack BK	Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy.	PloS one	2012	33
24705491	14069	Fahs SA	A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII.	Blood	2014	32
11226238	14080	Wolfrum C	Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus.	Proceedings of the National Academy of Sciences of the United States of America	2001	93
14534295	14080	Newberry EP	Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene.	The Journal of biological chemistry	2003	89
17058218	14080	Newberry EP	Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice.	Hepatology	2006	65
20537520	14080	Atshaves BP	Liver fatty acid-binding protein and obesity.	The Journal of nutritional biochemistry	2010	67
9358753	14085	Overturf K	Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes.	The American journal of pathology	1997	113
11062533	14085	Lagasse E	Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.	Nature medicine	2000	339
12665832	14085	Wang X	Cell fusion is the principal source of bone-marrow-derived hepatocytes.	Nature	2003	260
12665833	14085	Vassilopoulos G	Transplanted bone marrow regenerates liver by cell fusion.	Nature	2003	190
12902545	14085	Wang X	The origin and liver repopulating capacity of murine oval cells.	Proceedings of the National Academy of Sciences of the United States of America	2003	106
15195088	14085	Willenbring H	Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.	Nature medicine	2004	85
17664939	14085	Azuma H	Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice.	Nature biotechnology	2007	158
21562492	14085	Huang P	Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors.	Nature	2011	222
22863619	14085	Duncan AW	Aneuploidy as a mechanism for stress-induced liver adaptation.	The Journal of clinical investigation	2012	36
22996664	14085	Vaughan AM	Complete Plasmodium falciparum liver-stage development in liver-chimeric mice.	The Journal of clinical investigation	2012	47
23354049	14085	Huch M	In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration.	Nature	2013	205
23871605	14085	Yu B	Reprogramming fibroblasts into bipotential hepatic stem cells by defined factors.	Cell stem cell	2013	33
24582927	14085	Huang P	Direct reprogramming of human fibroblasts to functional and expandable hepatocytes.	Cell stem cell	2014	65
24681508	14085	Yin H	Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.	Nature biotechnology	2014	155
8833906	14104	Shimano H	Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.	The Journal of clinical investigation	1996	185
9062341	14104	Shimano H	Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells.	The Journal of clinical investigation	1997	176
10875926	14104	Loftus TM	Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors.	Science	2000	147
12840063	14104	Xu A	The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.	The Journal of clinical investigation	2003	253
16054078	14104	Chakravarthy MV	"New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.	Cell metabolism	2005	162
19724016	14104	Yamazaki Y	Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.	American journal of physiology. Endocrinology and metabolism	2009	54
20218765	14104	Strable MS	Genetic control of de novo lipogenesis: role in diet-induced obesity.	Critical reviews in biochemistry and molecular biology	2010	65
20655949	14104	Kaur G	Docosapentaenoic acid (22:5n-3): a review of its biological effects.	Progress in lipid research	2011	37
21389266	14104	Wu M	Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2011	42
22768070	14104	Guo X	Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice.	PloS one	2012	31
25038053	14104	Goedeke L	Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice.	EMBO molecular medicine	2014	31
16213224	14170	Inagaki T	Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.	Cell metabolism	2005	358
21436455	14170	Kir S	FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.	Science	2011	102
22309595	14170	Miura S	Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma.	BMC cancer	2012	35
22442730	14170	Yang C	Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.	PloS one	2012	36
23292666	14170	Uriarte I	Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice.	Gut	2013	37
23801799	14170	Gerhard GS	A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass.	Diabetes care	2013	33
24024127	14170	Adams AC	The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue.	Molecular metabolism	2012	68
24656817	14170	Degirolamo C	Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice.	Cell reports	2014	29
25776529	14170	Hagel M	First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.	Cancer discovery	2015	20
11138012	14245	Péterfy M	Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin.	Nature genetics	2001	188
16049017	14245	Péterfy M	Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis.	The Journal of biological chemistry	2005	77
16950137	14245	Finck BN	Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway.	Cell metabolism	2006	173
17105729	14245	Harris TE	Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1.	The Journal of biological chemistry	2007	84
17158099	14245	Donkor J	Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns.	The Journal of biological chemistry	2007	121
18791037	14245	Reue K	Thematic Review Series: Glycerolipids. Multiple roles for lipins/phosphatidate phosphatase enzymes in lipid metabolism.	Journal of lipid research	2008	68
19717560	14245	Donkor J	A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2.	The Journal of biological chemistry	2009	49
21816276	14245	Peterson TR	mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway.	Cell	2011	231
11557972	14377	Yoon JC	Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.	Nature	2001	467
17360978	14377	Zhang Y	Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms.	Diabetes	2007	98
26403433	14377	Xin C	Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway.	International journal of obesity	2016	11
23562828	14466	Takahashi Y	Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection.	Journal of biotechnology	2013	50
24441827	14466	Vitner EB	RIPK3 as a potential therapeutic target for Gaucher's disease.	Nature medicine	2014	26
25669322	14466	Imai T	Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice.	Journal of extracellular vesicles	2015	21
12552113	14527	Gelling RW	Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.	Proceedings of the National Academy of Sciences of the United States of America	2003	128
17131145	14527	Conarello SL	Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.	Diabetologia	2007	56
19046568	14527	Longuet C	The glucagon receptor is required for the adaptive metabolic response to fasting.	Cell metabolism	2008	52
19602537	14527	Pocai A	Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.	Diabetes	2009	48
22214853	14527	Unger RH	Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.	The Journal of clinical investigation	2012	116
23305646	14527	Habegger KM	Fibroblast growth factor 21 mediates specific glucagon actions.	Diabetes	2013	26
15536017	14599	Bartke A	Life extension in the dwarf mouse.	Current topics in developmental biology	2004	111
18585098	14599	Inagaki T	Inhibition of growth hormone signaling by the fasting-induced hormone FGF21.	Cell metabolism	2008	107
24341939	14599	Gong Z	Reductions in serum IGF-1 during aging impair health span.	Aging cell	2014	21
15184668	14775	McClung JP	Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase.	Proceedings of the National Academy of Sciences of the United States of America	2004	94
18445702	14775	Han ES	The in vivo gene expression signature of oxidative stress.	Physiological genomics	2008	57
19076066	14775	Sunde RA	Selenium status highly regulates selenoprotein mRNA levels for only a subset of the selenoproteins in the selenoproteome.	Bioscience reports	2009	54
19776219	14775	Zhang Y	Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity.	The journals of gerontology. Series A, Biological sciences and medical sciences	2009	68
9482913	15216	Zhou XY	HFE gene knockout produces mouse model of hereditary hemochromatosis.	Proceedings of the National Academy of Sciences of the United States of America	1998	112
12606179	15216	Bridle KR	Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.	Lancet	2003	132
15684062	15216	Lee P	Regulation of hepcidin transcription by interleukin-1 and interleukin-6.	Proceedings of the National Academy of Sciences of the United States of America	2005	105
18316026	15216	Schmidt PJ	The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.	Cell metabolism	2008	92
19824072	15216	Wallace DF	Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload.	Hepatology	2009	53
21364282	15216	Castoldi M	The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice.	The Journal of clinical investigation	2011	67
23524968	15216	Guo S	Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.	The Journal of clinical investigation	2013	42
7854452	15234	Schmidt C	Scatter factor/hepatocyte growth factor is essential for liver development.	Nature	1995	274
7854453	15234	Uehara Y	Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor.	Nature	1995	197
15249655	15234	Borowiak M	Met provides essential signals for liver regeneration.	Proceedings of the National Academy of Sciences of the United States of America	2004	128
21068842	15234	Ding BS	Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration.	Nature	2010	148
21199531	15234	Nakamura T	Hepatocyte growth factor twenty years on: Much more than a growth factor.	Journal of gastroenterology and hepatology	2011	80
22095660	15234	Ishikawa T	Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice.	Hepatology	2012	39
10391216	15289	Calogero S	The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice.	Nature genetics	1999	136
15795240	15289	Tsung A	The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion.	The Journal of experimental medicine	2005	317
17475888	15289	Fan J	Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling.	Journal of immunology	2007	84
17652366	15289	Levy RM	Systemic inflammation and remote organ injury following trauma require HMGB1.	American journal of physiology. Regulatory, integrative and comparative physiology	2007	73
18574060	15289	Andrassy M	High-mobility group box-1 in ischemia-reperfusion injury of the heart.	Circulation	2008	147
19454652	15289	Davé SH	Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis.	Journal of leukocyte biology	2009	48
19783637	15289	Antoine DJ	High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo.	Toxicological sciences 	2009	65
19902481	15289	Bamboat ZM	Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.	Hepatology	2010	62
19931603	15289	Martin-Murphy BV	The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice.	Toxicology letters	2010	52
20811657	15289	Antoine DJ	Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity.	Molecular medicine	2010	43
21809356	15289	Li L	Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.	Hepatology	2011	43
22105604	15289	Yang H	Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1).	Molecular medicine	2012	124
22821628	15289	Wang X	High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of γδ T cells with macrophages.	Hepatology	2013	35
24928512	15289	Ge X	High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD).	The Journal of biological chemistry	2014	27
25559892	15289	Yang H	MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.	The Journal of experimental medicine	2015	38
25562324	15289	Huebener P	The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.	The Journal of clinical investigation	2015	48
25681553	15289	Liu Y	Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9.	Journal of hepatology	2015	21
26037082	15289	Zhang W	Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo.	Journal of the American Heart Association	2015	15
26759232	15289	Tohme S	Neutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress.	Cancer research	2016	20
26818617	15289	Arriazu E	Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.	Gut	2017	10
9380735	15368	Poss KD	Heme oxygenase 1 is required for mammalian iron reutilization.	Proceedings of the National Academy of Sciences of the United States of America	1997	206
9380736	15368	Poss KD	Reduced stress defense in heme oxygenase 1-deficient cells.	Proceedings of the National Academy of Sciences of the United States of America	1997	225
15841216	15368	Duranski MR	Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver.	The Journal of clinical investigation	2005	196
19706490	15368	Seixas E	Heme oxygenase-1 affords protection against noncerebral forms of severe malaria.	Proceedings of the National Academy of Sciences of the United States of America	2009	79
20052772	15368	Mandal P	The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat Kupffer cells.	Hepatology	2010	46
20844238	15368	Kovtunovych G	Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution.	Blood	2010	62
21437926	15368	Carchman EH	Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice.	Hepatology	2011	57
21454555	15368	Piantadosi CA	Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression.	The Journal of biological chemistry	2011	66
23630967	15368	Silva-Gomes S	Heme catabolism by heme oxygenase-1 confers host resistance to Mycobacterium infection.	Infection and immunity	2013	27
24995976	15368	Jais A	Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man.	Cell	2014	41
25843659	15368	Zimmermann K	Activated AMPK boosts the Nrf2/HO-1 signaling axis--A role for the unfolded protein response.	Free radical biology and medicine	2015	19
10691738	15378	Li J	Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha.	Genes and development	2000	107
11158324	15378	Hayhurst GP	Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.	Molecular and cellular biology	2001	273
12651943	15378	Rhee J	Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2003	154
16618389	15378	Garrison WD	Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon.	Gastroenterology	2006	61
18971312	15378	Yagi S	DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) in mouse promoter regions demonstrating tissue-specific gene expression.	Genome research	2008	56
19637192	15378	Kang X	Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha.	Hepatology	2009	49
22241473	15378	Bonzo JA	Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice.	The Journal of biological chemistry	2012	42
25043045	15378	Saha SK	Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.	Nature	2014	51
10207053	16000	Frasca F	Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.	Molecular and cellular biology	1999	186
10359843	16000	Sjögren K	Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice.	Proceedings of the National Academy of Sciences of the United States of America	1999	118
10377413	16000	Yakar S	Normal growth and development in the absence of hepatic insulin-like growth factor I.	Proceedings of the National Academy of Sciences of the United States of America	1999	223
11159816	16000	Le Roith D	The somatomedin hypothesis: 2001.	Endocrine reviews	2001	151
12235108	16000	Yakar S	Circulating levels of IGF-1 directly regulate bone growth and density.	The Journal of clinical investigation	2002	177
15924568	16000	Miller RA	Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance.	Aging cell	2005	168
17416680	16000	Okada T	Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2007	92
19589948	16000	Ohlsson C	The role of liver-derived insulin-like growth factor-I.	Endocrine reviews	2009	71
22021391	16000	Bailey-Downs LC	Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging.	The journals of gerontology. Series A, Biological sciences and medical sciences	2012	50
22693205	16000	Steinbaugh MJ	Activation of genes involved in xenobiotic metabolism is a shared signature of mouse models with extended lifespan.	American journal of physiology. Endocrinology and metabolism	2012	35
23771523	16000	Quinn BJ	Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling.	Cancer prevention research	2013	26
24655348	16000	Leontieva OV	Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet.	Aging cell	2014	30
26094889	16000	Brandhorst S	A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan.	Cell metabolism	2015	53
10195897	16150	Li Q	Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.	Science	1999	235
10229185	16150	Tanaka M	Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice.	Immunity	1999	131
10359587	16150	Li ZW	The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis.	The Journal of experimental medicine	1999	238
12540784	16150	Li Z	Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.	Hepatology	2003	157
14614859	16150	Maeda S	IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha.	Immunity	2003	103
15685170	16150	Arkan MC	IKK-beta links inflammation to obesity-induced insulin resistance.	Nature medicine	2005	470
15685173	16150	Cai D	Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.	Nature medicine	2005	490
15989949	16150	Maeda S	IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.	Cell	2005	313
16807293	16150	Sakurai T	Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.	Proceedings of the National Academy of Sciences of the United States of America	2006	124
18577694	16150	Bradley RL	Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice.	American journal of physiology. Endocrinology and metabolism	2008	67
19683471	16150	Tanti JF	Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation.	Current opinion in pharmacology	2009	87
20227042	16150	He G	Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.	Cancer cell	2010	104
22828956	16150	Carvalho BM	Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice.	Diabetologia	2012	46
9844629	16337	Brüning JC	A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.	Molecular cell	1998	299
10642598	16337	Kido Y	Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.	The Journal of clinical investigation	2000	94
10949030	16337	Michael MD	Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.	Molecular cell	2000	285
17550779	16337	Könner AC	Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production.	Cell metabolism	2007	176
17767907	16337	Matsumoto M	Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.	Cell metabolism	2007	176
18587407	16337	Biddinger SB	Hepatic insulin resistance directly promotes formation of cholesterol gallstones.	Nature medicine	2008	55
19933998	16337	Lin HV	Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons.	Diabetes	2010	52
20407209	16337	Shimizu I	Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents.	The Journal of clinical investigation	2010	48
22404968	16337	Tiganis T	PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis.	The FEBS journal	2013	26
9038347	16367	Brüning JC	Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles.	Cell	1997	137
9495343	16367	Withers DJ	Disruption of IRS-2 causes type 2 diabetes in mice.	Nature	1998	319
11078455	16367	Kubota N	Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia.	Diabetes	2000	96
15372107	16367	Kulkarni RN	PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance.	The Journal of clinical investigation	2004	86
15711641	16367	Taniguchi CM	Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism.	The Journal of clinical investigation	2005	66
17709744	16367	Tremblay F	Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2007	126
18590693	16367	Dong XC	Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation.	Cell metabolism	2008	126
19066218	16367	Choi CS	Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2008	102
19596788	16367	Guo S	The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis.	Molecular and cellular biology	2009	47
20074531	16367	Copps KD	Irs1 serine 307 promotes insulin sensitivity in mice.	Cell metabolism	2010	65
21731668	16367	Macotela Y	Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolism.	PloS one	2011	65
22902548	16367	Zheng Z	Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model.	Journal of hepatology	2013	35
25706874	16367	Li P	LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes.	Nature medicine	2015	25
8349823	16835	Ishibashi S	Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.	The Journal of clinical investigation	1993	333
12032330	16835	Joseph SB	Synthetic LXR ligand inhibits the development of atherosclerosis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2002	187
16873680	16835	Zang M	Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice.	Diabetes	2006	162
18239153	16835	Subramanian S	Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2008	62
18249172	16835	Biddinger SB	Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.	Cell metabolism	2008	138
18666236	16835	Wouters K	Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.	Hepatology	2008	118
19478200	16835	Verschuren L	MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease.	Circulation research	2009	46
19520913	16835	Zelcer N	LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.	Science	2009	189
20816088	16835	Kjolby M	Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export.	Cell metabolism	2010	57
21690266	16835	Subramanian S	Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.	Journal of lipid research	2011	50
21703998	16835	Van Rooyen DM	Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis.	Gastroenterology	2011	49
22223731	16835	Derwall M	Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2012	47
23288159	16835	Marquart TJ	Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2013	46
23426179	16835	Klingenberg R	Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.	The Journal of clinical investigation	2013	61
23702658	16835	Rotllan N	Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report.	Arteriosclerosis, thrombosis, and vascular biology	2013	45
26437365	16835	Goedeke L	MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.	Nature medicine	2015	22
9311777	16846	Kamohara S	Acute stimulation of glucose metabolism in mice by leptin treatment.	Nature	1997	110
10485707	16846	Shimomura I	Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.	Nature	1999	168
10949029	16846	Shimomura I	Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.	Molecular cell	2000	175
10973319	16846	Lin HZ	Metformin reverses fatty liver disease in obese, leptin-deficient mice.	Nature medicine	2000	120
11533494	16846	Yuan M	Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.	Science	2001	421
11915021	16846	Saxena NK	Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice.	Hepatology	2002	82
12114623	16846	Cohen P	Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss.	Science	2002	159
12618528	16846	Matsusue K	Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.	The Journal of clinical investigation	2003	130
14976145	16846	Fu L	Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.	Endocrinology	2004	126
16123334	16846	Li J	Intermittent hypoxia induces hyperlipidemia in lean mice.	Circulation research	2005	88
16790840	16846	Wang Y	Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.	Journal of lipid research	2006	67
17465682	16846	Medina-Gomez G	PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.	PLoS genetics	2007	116
17909097	16846	Kim YD	Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.	Diabetes	2008	92
18687777	16846	Coskun T	Fibroblast growth factor 21 corrects obesity in mice.	Endocrinology	2008	216
21865462	16846	Enriori PJ	Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance.	The Journal of neuroscience 	2011	82
22844426	16846	Gauffin Cano P	Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity.	PloS one	2012	38
23618531	16846	Wahlang B	Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.	The Journal of nutritional biochemistry	2013	29
24011077	16846	Fujikawa T	Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin.	Cell metabolism	2013	32
24316659	16846	Ge ZJ	DNA methylation in oocytes and liver of female mice and their offspring: effects of high-fat-diet-induced obesity.	Environmental health perspectives	2014	22
15995182	16956	Millar JS	Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339.	Journal of lipid research	2005	79
18344982	16956	Chen Y	Variations in DNA elucidate molecular networks that cause disease.	Nature	2008	364
22562834	16956	Delezie J	The nuclear receptor REV-ERBα is required for the daily balance of carbohydrate and lipid metabolism.	FASEB journal 	2012	34
10225972	17777	Raabe M	Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice.	The Journal of clinical investigation	1999	99
23749231	17777	Soh J	MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion.	Nature medicine	2013	50
9240432	18024	Itoh K	An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.	Biochemical and biophysical research communications	1997	704
11134556	18024	Enomoto A	High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes.	Toxicological sciences 	2001	164
11248092	18024	Ramos-Gomez M	Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	2001	271
11287661	18024	Chan K	An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen.	Proceedings of the National Academy of Sciences of the United States of America	2001	191
12506115	18024	Kwak MK	Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival.	The Journal of biological chemistry	2003	180
12653965	18024	Itoh K	Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles.	Genes to cells 	2003	174
14612418	18024	Kwak MK	Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway.	Molecular and cellular biology	2003	103
15374950	18024	Iida K	Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.	Cancer research	2004	92
15519281	18024	Motohashi H	Nrf2-Keap1 defines a physiologically important stress response mechanism.	Trends in molecular medicine	2004	308
16293230	18024	Okawa H	Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity.	Biochemical and biophysical research communications	2006	115
16487040	18024	Cho HY	Nrf2 defends the lung from oxidative stress.	Antioxidants and redox signaling	2006	124
16489057	18024	Yates MS	Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oylimidazole.	Cancer research	2006	69
16516379	18024	Hu R	Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice.	Cancer letters	2006	69
16968214	18024	Kensler TW	Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.	Annual review of pharmacology and toxicology	2007	723
17562481	18024	Aleksunes LM	Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.	Toxicologic pathology	2007	84
17668877	18024	Maher JM	Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway.	Hepatology	2007	87
18059474	18024	Beyer TA	Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance.	The EMBO journal	2008	68
18281592	18024	Tanaka Y	NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet.	The Journal of pharmacology and experimental therapeutics	2008	70
18826952	18024	Ohtsuji M	Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes.	The Journal of biological chemistry	2008	74
19129213	18024	Reisman SA	Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species.	Toxicological sciences 	2009	49
19386581	18024	Yates MS	Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.	Carcinogenesis	2009	74
19646463	18024	Cho HY	Nrf2 protects against airway disorders.	Toxicology and applied pharmacology	2010	58
19698707	18024	Shin S	Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.	European journal of pharmacology	2009	72
19914374	18024	Chowdhry S	Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis.	Free radical biology and medicine	2010	51
20089859	18024	Pi J	Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity.	The Journal of biological chemistry	2010	63
20122946	18024	Klaassen CD	Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver.	Toxicology and applied pharmacology	2010	75
20350562	18024	Zhang YK	Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.	Toxicology and applied pharmacology	2010	42
20628156	18024	Wakabayashi N	Regulation of notch1 signaling by nrf2: implications for tissue regeneration.	Science signaling	2010	56
21482715	18024	Inami Y	Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells.	The Journal of cell biology	2011	131
21775727	18024	Wu KC	Beneficial role of Nrf2 in regulating NADPH generation and consumption.	Toxicological sciences 	2011	50
21852674	18024	Chartoumpekis DV	Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice.	Diabetes	2011	40
22188542	18024	Xue M	Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation.	The Biochemical journal	2012	43
22312014	18024	MacGarvey NC	Activation of mitochondrial biogenesis by heme oxygenase-1-mediated NF-E2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis.	American journal of respiratory and critical care medicine	2012	36
22751928	18024	Rada P	Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis.	Molecular and cellular biology	2012	49
22872865	18024	Taguchi K	Keap1 degradation by autophagy for the maintenance of redox homeostasis.	Proceedings of the National Academy of Sciences of the United States of America	2012	80
22936178	18024	Xu J	Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.	Diabetes	2012	34
22966037	18024	Ma Q	Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2.	Pharmacological reviews	2012	51
23274085	18024	Bae SH	Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage.	Cell metabolism	2013	67
24206218	18024	Ludtmann MH	Nrf2 affects the efficiency of mitochondrial fatty acid oxidation.	The Biochemical journal	2014	24
24298019	18024	Wakabayashi N	Notch-Nrf2 axis: regulation of Nrf2 gene expression and cytoprotection by notch signaling.	Molecular and cellular biology	2014	21
24310875	18024	Köhler UA	Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell-cycle control and apoptosis.	Hepatology	2014	24
24958099	18024	Meakin PJ	Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance.	Molecular and cellular biology	2014	22
25049227	18024	Kageyama S	Proteasome dysfunction activates autophagy and the Keap1-Nrf2 pathway.	The Journal of biological chemistry	2014	22
16950136	18145	Marí M	Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis.	Cell metabolism	2006	149
18077828	18145	Liu B	Genetic variations and treatments that affect the lifespan of the NPC1 mouse.	Journal of lipid research	2008	52
19171898	18145	Liu B	Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse.	Proceedings of the National Academy of Sciences of the United States of America	2009	115
19965601	18145	Liu B	Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid.	Journal of lipid research	2010	58
20357695	18145	Ward S	2-hydroxypropyl-beta-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease.	Pediatric research	2010	43
20581737	18145	Ramirez CM	Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.	Pediatric research	2010	51
21697390	18145	Aqul A	Unesterified cholesterol accumulation in late endosomes/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment.	The Journal of neuroscience 	2011	42
22048958	18145	Maue RA	A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.	Human molecular genetics	2012	30
23881911	18145	Fan M	Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profiling.	Journal of lipid research	2013	26
26888431	18145	Alam MS	Chronic administration of an HDAC inhibitor treats both neurological and systemic Niemann-Pick type C disease in a mouse model.	Science translational medicine	2016	10
9770465	18171	Bertilsson G	Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.	Proceedings of the National Academy of Sciences of the United States of America	1998	131
15340055	18171	Kodama S	Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes.	Molecular and cellular biology	2004	99
16841097	18171	Zhou C	Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation.	The Journal of clinical investigation	2006	98
26829317	18416	Yang Y	A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice.	Nature biotechnology	2016	28
9242918	18534	Hanson RW	Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression.	Annual review of biochemistry	1997	123
12882911	18534	Rossmeisl M	Variation in type 2 diabetes--related traits in mouse strains susceptible to diet-induced obesity.	Diabetes	2003	83
17403375	18534	Burgess SC	Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver.	Cell metabolism	2007	89
20133650	18534	Li S	Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2010	181
22065779	18534	Merritt ME	Flux through hepatic pyruvate carboxylase and phosphoenolpyruvate carboxykinase detected by hyperpolarized 13C magnetic resonance.	Proceedings of the National Academy of Sciences of the United States of America	2011	35
8106172	18670	Smit JJ	Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease.	Cell	1993	199
15236191	18670	Fickert P	Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.	Gastroenterology	2004	76
15329734	18670	Pikarsky E	NF-kappaB functions as a tumour promoter in inflammation-associated cancer.	Nature	2004	547
21912653	18670	Philips GM	Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer.	PloS one	2011	44
23049784	18670	Sancho P	NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.	PloS one	2012	35
23540693	18670	Shukla R	Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma.	Cell	2013	112
7539101	19013	Lee SS	Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.	Molecular and cellular biology	1995	264
9488698	19013	Aoyama T	Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).	The Journal of biological chemistry	1998	145
10359558	19013	Kersten S	Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.	The Journal of clinical investigation	1999	335
10377439	19013	Leone TC	A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.	Proceedings of the National Academy of Sciences of the United States of America	1999	222
10862772	19013	Kersten S	Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene.	The Journal of biological chemistry	2000	111
12805656	19013	Hurst CH	Activation of PPARalpha and PPARgamma by environmental phthalate monoesters.	Toxicological sciences 	2003	93
12829994	19013	Ip E	Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.	Hepatology	2003	79
15107844	19013	Koo SH	PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.	Nature medicine	2004	155
15122757	19013	Ip E	Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice.	Hepatology	2004	73
15578089	19013	Li AC	Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.	The Journal of clinical investigation	2004	124
16108051	19013	You M	Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice.	Hepatology	2005	77
17130488	19013	Wolins NE	OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization.	Diabetes	2006	99
17234449	19013	Dalen KT	LSDP5 is a PAT protein specifically expressed in fatty acid oxidizing tissues.	Biochimica et biophysica acta	2007	63
17438130	19013	Shah YM	Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation.	Molecular and cellular biology	2007	74
17550778	19013	Badman MK	Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.	Cell metabolism	2007	360
17601491	19013	Lundåsen T	PPARalpha is a key regulator of hepatic FGF21.	Biochemical and biophysical research communications	2007	92
17652171	19013	Rozema DB	Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes.	Proceedings of the National Academy of Sciences of the United States of America	2007	126
17892536	19013	Kleemann R	Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis.	Genome biology	2007	57
18006136	19013	Gonzalez FJ	PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators.	Toxicology	2008	69
18188449	19013	Tanaka N	PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.	The Journal of clinical investigation	2008	65
18323516	19013	Rigamonti E	Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.	Arteriosclerosis, thrombosis, and vascular biology	2008	62
18467542	19013	Muise ES	Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states.	Molecular pharmacology	2008	72
19549860	19013	Crawford PA	Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation.	Proceedings of the National Academy of Sciences of the United States of America	2009	77
19646743	19013	Chakravarthy MV	Identification of a physiologically relevant endogenous ligand for PPARalpha in liver.	Cell	2009	145
19805517	19013	Sanderson LM	Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver.	Molecular and cellular biology	2009	49
20089785	19013	Takikawa M	Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice.	The Journal of nutrition	2010	66
20197053	19013	Hondares E	Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat.	Cell metabolism	2010	78
20414453	19013	Pyper SR	PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.	Nuclear receptor signaling	2010	103
21346097	19013	Abdelmegeed MA	PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver.	The Journal of nutrition	2011	47
21641555	19013	Ahmadian M	Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype.	Cell metabolism	2011	119
22012983	19013	Yatsuga S	Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice.	Human molecular genetics	2012	34
22158963	19013	Boergesen M	Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sites.	Molecular and cellular biology	2012	74
22722857	19013	Cipolletta D	PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells.	Nature	2012	191
23134073	19013	Woo YC	Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.	Clinical endocrinology	2013	37
24424044	19013	Kim H	Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor α to regulate metabolic hormone FGF21.	Endocrinology	2014	23
24506873	19013	Adamovich Y	Circadian clocks and feeding time regulate the oscillations and levels of hepatic triglycerides.	Cell metabolism	2014	44
25383539	19013	Lee JM	Nutrient-sensing nuclear receptors coordinate autophagy.	Nature	2014	63
25695945	19013	den Besten G	Short-Chain Fatty Acids Protect Against High-Fat Diet-Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation.	Diabetes	2015	40
26838599	19013	Montagner A	Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.	Gut	2016	20
8647948	19016	Vidal-Puig A	Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.	The Journal of clinical investigation	1996	125
12401792	19016	Yu S	Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression.	The Journal of biological chemistry	2003	145
12805374	19016	Gavrilova O	Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.	The Journal of biological chemistry	2003	185
12925701	19016	Norris AW	Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.	The Journal of clinical investigation	2003	108
14625542	19016	Hevener AL	Muscle-specific Pparg deletion causes insulin resistance.	Nature medicine	2003	136
14660788	19016	He W	Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.	Proceedings of the National Academy of Sciences of the United States of America	2003	293
15833818	19016	Jones JR	Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2005	114
16125673	19016	Inoue M	Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.	Biochemical and biophysical research communications	2005	78
16326714	19016	Nawrocki AR	Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists.	The Journal of biological chemistry	2006	200
16613991	19016	Grün F	Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates.	Molecular endocrinology	2006	107
17304352	19016	Duan SZ	Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality.	The Journal of clinical investigation	2007	65
17488638	19016	Waki H	The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression.	Cell metabolism	2007	61
17515919	19016	Odegaard JI	Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.	Nature	2007	537
17525798	19016	Hevener AL	Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones.	The Journal of clinical investigation	2007	173
18541527	19016	Stienstra R	Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue.	The Journal of biological chemistry	2008	56
19906798	19016	Kliewer SA	Fibroblast growth factor 21: from pharmacology to physiology.	The American journal of clinical nutrition	2010	69
21532596	19016	Lu M	Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones.	Nature medicine	2011	77
12754525	19017	Puigserver P	Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.	Nature	2003	363
14729567	19017	Zhang Y	Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR.	Genes and development	2004	82
15454086	19017	Lin J	Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice.	Cell	2004	385
16122419	19017	Handschin C	Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha.	Cell	2005	74
16753578	19017	Lerin C	GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha.	Cell metabolism	2006	144
17086191	19017	Baur JA	Resveratrol improves health and survival of mice on a high-calorie diet.	Nature	2006	1034
17476214	19017	Liu C	Transcriptional coactivator PGC-1alpha integrates the mammalian clock and energy metabolism.	Nature	2007	196
19541642	19017	Potthoff MJ	FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response.	Proceedings of the National Academy of Sciences of the United States of America	2009	159
19542201	19017	Bugger H	Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice.	Diabetes	2009	51
20018698	19017	Estall JL	PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis.	Proceedings of the National Academy of Sciences of the United States of America	2009	55
21712364	19017	Fisher FM	Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo.	Endocrinology	2011	58
21914785	19017	Bhalla K	PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis.	Cancer research	2011	44
22252943	19017	Holmström MH	Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes.	American journal of physiology. Endocrinology and metabolism	2012	32
22355589	19017	Minor RK	SRT1720 improves survival and healthspan of obese mice.	Scientific reports	2011	80
22645355	19017	Kleiner S	Development of insulin resistance in mice lacking PGC-1α in adipose tissues.	Proceedings of the National Academy of Sciences of the United States of America	2012	64
24590984	19017	Ye D	Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice.	Hepatology	2014	24
10469643	19662	Quadro L	Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein.	The EMBO journal	1999	123
16034410	19662	Yang Q	Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.	Nature	2005	430
22431523	19662	Norseen J	Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism.	Molecular and cellular biology	2012	56
24606904	19662	Moraes-Vieira PM	RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance.	Cell metabolism	2014	39
11030617	20186	Sinal CJ	Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.	Cell	2000	326
16410358	20186	Zhang Y	Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	178
16446356	20186	Cariou B	The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.	The Journal of biological chemistry	2006	99
16557297	20186	Ma K	Farnesoid X receptor is essential for normal glucose homeostasis.	The Journal of clinical investigation	2006	159
17183066	20186	Kim I	Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice.	Carcinogenesis	2007	100
17283114	20186	Yang F	Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.	Cancer research	2007	125
17720959	20186	Kim I	Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.	Journal of lipid research	2007	131
19126757	20186	Lefebvre P	Role of bile acids and bile acid receptors in metabolic regulation.	Physiological reviews	2009	261
20091679	20186	Thomas AM	Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine.	Hepatology	2010	71
20185821	20186	Lee J	A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition.	The Journal of biological chemistry	2010	65
20483916	20186	Chong HK	Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1.	Nucleic acids research	2010	41
21430080	20186	Wolfe A	Increased activation of the Wnt/β-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice.	The Journal of pharmacology and experimental therapeutics	2011	41
21593203	20186	Prawitt J	Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity.	Diabetes	2011	63
21632533	20186	Watanabe M	Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure.	The Journal of biological chemistry	2011	55
22057115	20186	Modica S	Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.	Gastroenterology	2012	38
23395169	20186	Sayin SI	Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.	Cell metabolism	2013	224
23460643	20186	McMahan RH	Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease.	The Journal of biological chemistry	2013	32
25500885	20186	Jiang C	Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.	The Journal of clinical investigation	2015	51
26670557	20186	Jiang C	Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.	Nature communications	2015	24
26740296	20186	Parséus A	Microbiota-induced obesity requires farnesoid X receptor.	Gut	2017	15
15096593	20249	Dobrzyn P	Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver.	Proceedings of the National Academy of Sciences of the United States of America	2004	85
15855315	20249	Biddinger SB	Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome.	Diabetes	2005	79
17082365	20249	Li J	Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia.	Journal of applied physiology	2007	61
18054317	20249	Miyazaki M	Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis.	Cell metabolism	2007	92
18460915	20249	Flowers MT	Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism.	Current opinion in lipidology	2008	80
19119140	20249	Li ZZ	Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.	The Journal of biological chemistry	2009	107
21856199	20249	Hirschey MD	SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome.	Molecular cell	2011	159
15670778	20303	Seo MJ	Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo.	Biochemical and biophysical research communications	2005	92
16515819	20303	Melhem A	Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.	Journal of hepatology	2006	64
23838178	20303	Fuchs BC	Molecular MRI of collagen to diagnose and stage liver fibrosis.	Journal of hepatology	2013	26
23959503	20303	De Minicis S	Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.	Hepatology	2014	39
24677161	20303	Schliess F	Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration.	Hepatology	2014	24
25722117	20303	Park M	Tonsil-derived mesenchymal stem cells ameliorate CCl4-induced liver fibrosis in mice via autophagy activation.	Scientific reports	2015	17
26222337	20303	Lan T	Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.	PloS one	2015	18
9163428	20778	Kozarsky KF	Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels.	Nature	1997	126
9356497	20778	Rigotti A	A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism.	Proceedings of the National Academy of Sciences of the United States of America	1997	190
10872459	20778	Krieger M	Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI.	Annual review of biochemistry	1999	102
12356718	20778	Scarselli E	The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.	The EMBO journal	2002	371
12788804	20778	Rigotti A	The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues.	Endocrine reviews	2003	106
16200214	20778	Zhang Y	Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.	The Journal of clinical investigation	2005	83
18064300	20778	Cai L	SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance.	The Journal of clinical investigation	2008	50
21953761	20778	Meuleman P	A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.	Hepatology	2012	41
9062340	20787	Shimomura I	Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells.	The Journal of clinical investigation	1997	157
9329978	20787	Shimano H	Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene.	The Journal of clinical investigation	1997	108
9600904	20787	Horton JD	Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice.	Proceedings of the National Academy of Sciences of the United States of America	1998	135
10514488	20787	Shimomura I	Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus.	The Journal of biological chemistry	1999	155
10585467	20787	Shimano H	Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes.	The Journal of biological chemistry	1999	119
11090130	20787	Repa JJ	Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.	Genes and development	2000	340
11090131	20787	Schultz JR	Role of LXRs in control of lipogenesis.	Genes and development	2000	308
11591434	20787	Shimano H	Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes.	Progress in lipid research	2001	109
11782483	20787	Liang G	Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.	The Journal of biological chemistry	2002	167
12036955	20787	You M	Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP).	The Journal of biological chemistry	2002	110
14512514	20787	Horton JD	Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes.	Proceedings of the National Academy of Sciences of the United States of America	2003	356
16054068	20787	Kalaany NY	LXRs regulate the balance between fat storage and oxidation.	Cell metabolism	2005	108
17107947	20787	Cha JY	The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.	The Journal of biological chemistry	2007	109
17921436	20787	Jeong HJ	Sterol-dependent regulation of proprotein convertase subtilisin/kexin type 9 expression by sterol-regulatory element binding protein-2.	Journal of lipid research	2008	58
18838740	20787	Moon YA	Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice.	Journal of lipid research	2009	51
18840786	20787	Xu J	Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.	Diabetes	2009	230
20817729	20787	Ponugoti B	SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism.	The Journal of biological chemistry	2010	111
21459323	20787	Li Y	AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.	Cell metabolism	2011	203
22414386	20787	Lee JS	Pharmacologic ER stress induces non-alcoholic steatohepatitis in an animal model.	Toxicology letters	2012	32
22682225	20787	Haas JT	Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression.	Cell metabolism	2012	47
24300912	20787	Horie T	MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.	Nature communications	2013	35
26282675	20787	Wu H	MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.	Gut	2016	11
16308421	20869	Shaw RJ	The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.	Science	2005	494
18482975	20869	Hou X	SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.	The Journal of biological chemistry	2008	210
20577053	20869	Foretz M	Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.	The Journal of clinical investigation	2010	251
21606593	20869	Miller RA	Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling.	The Journal of clinical investigation	2011	42
21930968	20869	MacIver NJ	The liver kinase B1 is a central regulator of T cell development, activation, and metabolism.	Journal of immunology	2011	63
23040072	20869	Su X	TAp63 is a master transcriptional regulator of lipid and glucose metabolism.	Cell metabolism	2012	31
25366347	20869	Morrison A	Sestrin2 promotes LKB1-mediated AMPK activation in the ischemic heart.	FASEB journal 	2015	24
25617365	20869	Rao F	Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1.	Proceedings of the National Academy of Sciences of the United States of America	2015	15
9630215	22259	Peet DJ	Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha.	Cell	1998	272
11149950	22259	Laffitte BA	LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.	Proceedings of the National Academy of Sciences of the United States of America	2001	132
11901146	22259	Repa JJ	Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta.	The Journal of biological chemistry	2002	137
12193651	22259	Tangirala RK	Identification of macrophage liver X receptors as inhibitors of atherosclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2002	91
12524534	22259	Joseph SB	Reciprocal regulation of inflammation and lipid metabolism by liver X receptors.	Nature medicine	2003	273
15146238	22259	Watanabe M	Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.	The Journal of clinical investigation	2004	212
15479645	22259	Joseph SB	LXR-dependent gene expression is important for macrophage survival and the innate immune response.	Cell	2004	134
15539622	22259	Levin N	Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists.	Arteriosclerosis, thrombosis, and vascular biology	2005	69
17187055	22259	Mitro N	The nuclear receptor LXR is a glucose sensor.	Nature	2007	122
17189208	22259	Chen W	Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice.	Cell metabolism	2007	83
17563384	22259	Zelcer N	Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors.	Proceedings of the National Academy of Sciences of the United States of America	2007	85
18292813	22259	Denechaud PD	ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver.	The Journal of clinical investigation	2008	55
19646905	22259	A-Gonzalez N	Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR.	Immunity	2009	145
20037595	22259	Villablanca EJ	Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses.	Nature medicine	2010	46
21266776	22259	Cui G	Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation.	The Journal of clinical investigation	2011	60
21562267	22259	Terwel D	Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis.	The Journal of neuroscience 	2011	46
23770640	22259	A-Gonzalez N	The nuclear receptor LXRα controls the functional specialization of splenic macrophages.	Nature immunology	2013	28
23823481	22259	Beaven SW	Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance.	Cell metabolism	2013	35
18948104	56636	Izumiya Y	FGF21 is an Akt-regulated myokine.	FEBS letters	2008	80
19470704	56636	Berglund ED	Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity.	Endocrinology	2009	80
19589869	56636	Hotta Y	Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.	Endocrinology	2009	83
19819944	56636	Badman MK	Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis.	Endocrinology	2009	104
20656789	56636	Tyynismaa H	Mitochondrial myopathy induces a starvation-like response.	Human molecular genetics	2010	51
21373720	56636	Chartoumpekis DV	Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21.	Molecular medicine	2011	53
22304921	56636	Dutchak PA	Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones.	Cell	2012	120
23066506	56636	Zhang Y	The starvation hormone, fibroblast growth factor-21, extends lifespan in mice.	eLife	2012	57
23202295	56636	Kim KH	Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine.	Nature medicine	2013	129
23663741	56636	Lin Z	Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.	Cell metabolism	2013	97
23667629	56636	Kim KH	Acute exercise induces FGF21 expression in mice and in healthy humans.	PloS one	2013	27
23766126	56636	Camporez JP	Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice.	Endocrinology	2013	34
23771152	56636	Planavila A	Fibroblast growth factor 21 protects against cardiac hypertrophy in mice.	Nature communications	2013	44
23933983	56636	Owen BM	FGF21 contributes to neuroendocrine control of female reproduction.	Nature medicine	2013	35
24401271	56636	Emanuelli B	Interplay between FGF21 and insulin action in the liver regulates metabolism.	The Journal of clinical investigation	2014	47
25008183	56636	Markan KR	Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding.	Diabetes	2014	55
25024372	56636	Liang Q	FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.	Diabetes	2014	25
26654352	56636	Fisher FM	Understanding the Physiology of FGF21.	Annual review of physiology	2016	19
26724858	56636	von Holstein-Rathlou S	FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver.	Cell metabolism	2016	18
17923681	64384	Lombard DB	Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation.	Molecular and cellular biology	2007	343
18794531	64384	Ahn BH	A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis.	Proceedings of the National Academy of Sciences of the United States of America	2008	325
20235147	64384	Bao J	Characterization of the murine SIRT3 mitochondrial localization sequence and comparison of mitochondrial enrichment and deacetylase activity of long and short SIRT3 isoforms.	Journal of cellular biochemistry	2010	42
20647045	64384	Bao J	SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity.	Free radical biology and medicine	2010	50
21044047	64384	Kendrick AA	Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation.	The Biochemical journal	2011	86
21109197	64384	Shimazu T	SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production.	Cell metabolism	2010	135
21255725	64384	Hallows WC	Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction.	Molecular cell	2011	107
21449565	64384	Fritz KS	4-Hydroxynonenal inhibits SIRT3 via thiol-specific modification.	Chemical research in toxicology	2011	52
22309199	64384	Fritz KS	Mitochondrial acetylome analysis in a mouse model of alcohol-induced liver injury utilizing SIRT3 knockout mice.	Journal of proteome research	2012	48
22645641	64384	Fernandez-Marcos PJ	Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis.	Scientific reports	2012	37
23201123	64384	Hebert AS	Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome.	Molecular cell	2013	137
23576753	64384	Rardin MJ	Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways.	Proceedings of the National Academy of Sciences of the United States of America	2013	90
24051248	64384	Peek CB	Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice.	Science	2013	125
25863253	64384	Dittenhafer-Reed KE	SIRT3 mediates multi-tissue coupling for metabolic fuel switching.	Cell metabolism	2015	15
26358839	64384	Weinert BT	Analysis of acetylation stoichiometry suggests that SIRT3 repairs nonenzymatic acetylation lesions.	The EMBO journal	2015	18
14672613	76282	Rinella ME	The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance.	Journal of hepatology	2004	87
16175608	76282	Li Z	Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.	Hepatology	2005	104
22198329	76282	Sharma V	Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles.	Mutation research	2012	35
23449255	76282	Bertola A	Mouse model of chronic and binge ethanol feeding (the NIAAA model).	Nature protocols	2013	93
25445398	76282	Idrissova L	TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess.	Journal of hepatology	2015	18
18335035	93759	Boily G	SirT1 regulates energy metabolism and response to caloric restriction in mice.	PloS one	2008	157
18550784	93759	Chen D	Tissue-specific regulation of SIRT1 by calorie restriction.	Genes and development	2008	179
18840364	93759	Banks AS	SirT1 gain of function increases energy efficiency and prevents diabetes in mice.	Cell metabolism	2008	234
18849969	93759	Liu Y	A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange.	Nature	2008	190
19046567	93759	Feige JN	Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation.	Cell metabolism	2008	254
19284563	93759	Smith JJ	Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo.	BMC systems biology	2009	77
19356714	93759	Purushotham A	Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.	Cell metabolism	2009	287
19429820	93759	Csiszar A	Resveratrol induces mitochondrial biogenesis in endothelial cells.	American journal of physiology. Heart and circulatory physiology	2009	101
20071779	93759	Escande C	Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice.	The Journal of clinical investigation	2010	71
20339025	93759	Xu F	Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammation.	Endocrinology	2010	63
20595232	93759	Walker AK	Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP.	Genes and development	2010	116
20647536	93759	Schug TT	Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress.	Molecular and cellular biology	2010	80
20889128	93759	D'Antona G	Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice.	Cell metabolism	2010	87
20975665	93759	Herranz D	Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer.	Nature communications	2010	156
21102633	93759	Herranz D	SIRT1: recent lessons from mouse models.	Nature reviews. Cancer	2010	86
21187328	93759	Palacios JA	SIRT1 contributes to telomere maintenance and augments global homologous recombination.	The Journal of cell biology	2010	61
21321189	93759	Li Y	Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver.	FASEB journal 	2011	75
22908267	93759	Cai W	Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.	Proceedings of the National Academy of Sciences of the United States of America	2012	44
23341587	93759	Bellet MM	Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1.	Proceedings of the National Academy of Sciences of the United States of America	2013	28
24262277	93759	Yin H	Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.	Gastroenterology	2014	32
24582957	93759	Mitchell SJ	The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet.	Cell reports	2014	64
12552133	100102	Seidah NG	The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation.	Proceedings of the National Academy of Sciences of the United States of America	2003	183
15385538	100102	Park SW	Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver.	The Journal of biological chemistry	2004	103
15654334	100102	Cohen J	Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.	Nature genetics	2005	253
15677715	100102	Maxwell KN	Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.	Proceedings of the National Academy of Sciences of the United States of America	2005	77
15805190	100102	Rashid S	Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9.	Proceedings of the National Academy of Sciences of the United States of America	2005	151
17080197	100102	Lagace TA	Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice.	The Journal of clinical investigation	2006	123
18039658	100102	Poirier S	The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2.	The Journal of biological chemistry	2008	73
18354138	100102	Grefhorst A	Plasma PCSK9 preferentially reduces liver LDL receptors in mice.	Journal of lipid research	2008	56
18666258	100102	Zaid A	Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.	Hepatology	2008	66
18695239	100102	Frank-Kamenetsky M	Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates.	Proceedings of the National Academy of Sciences of the United States of America	2008	143
19443683	100102	Chan JC	A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates.	Proceedings of the National Academy of Sciences of the United States of America	2009	80
21273557	100102	Roubtsova A	Circulating proprotein convertase subtilisin/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue.	Arteriosclerosis, thrombosis, and vascular biology	2011	40
22426206	100102	Ai D	Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice.	The Journal of clinical investigation	2012	32
23559630	100102	Le May C	Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1.	Arteriosclerosis, thrombosis, and vascular biology	2013	28
23690465	100102	Tavori H	Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.	Circulation	2013	39
24506872	100102	Gustafsen C	The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion.	Cell metabolism	2014	28
24603306	100102	Miranda MX	The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.	European heart journal	2015	18
24916110	100102	Ding Q	Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing.	Circulation research	2014	44
25341796	100102	Roche-Molina M	Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.	Arteriosclerosis, thrombosis, and vascular biology	2015	18
25830891	100102	Ran FA	In vivo genome editing using Staphylococcus aureus Cas9.	Nature	2015	251
26112889	100102	Winnik S	Protective effects of sirtuins in cardiovascular diseases: from bench to bedside.	European heart journal	2015	33
11283375	100705	Abu-Elheiga L	Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.	Science	2001	172
11956156	100705	Tomlinson E	Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity.	Endocrinology	2002	111
17923673	100705	Choi CS	Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity.	Proceedings of the National Academy of Sciences of the United States of America	2007	96
24185692	100705	Fullerton MD	Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin.	Nature medicine	2013	84
9867845	103988	Postic C	Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.	The Journal of biological chemistry	1999	378
12697904	103988	Laffitte BA	Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue.	Proceedings of the National Academy of Sciences of the United States of America	2003	103
12931191	103988	Danial NN	BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis.	Nature	2003	166
14985368	103988	Dentin R	Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.	The Journal of biological chemistry	2004	90
22521878	103988	Hagiwara A	Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.	Cell metabolism	2012	91
22111624	104086	Lorbek G	Cytochrome P450s in the synthesis of cholesterol and bile acids--from mouse models to human diseases.	The FEBS journal	2012	31
14749836	105675	Kokoszka JE	The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore.	Nature	2004	259
15792954	105675	Basso E	Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D.	The Journal of biological chemistry	2005	219
15800626	105675	Nakagawa T	Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death.	Nature	2005	418
15800627	105675	Baines CP	Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death.	Nature	2005	589
20942566	105675	Ramachandran A	Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury.	Free radical research	2011	44
18292224	106407	Rao A	The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis.	Proceedings of the National Academy of Sciences of the United States of America	2008	65
25641256	106407	Slijepcevic D	Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice.	Hepatology	2015	15
16717184	107476	Mao J	Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis.	Proceedings of the National Academy of Sciences of the United States of America	2006	62
23056479	107476	Fåk F	Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/- mice.	PloS one	2012	33
15038791	107869	Ishii I	Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression.	The Biochemical journal	2004	72
15863703	107869	Li L	Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse.	FASEB journal 	2005	138
21254839	107869	Kabil O	The quantitative significance of the transsulfuration enzymes for H2S production in murine tissues.	Antioxidants and redox signaling	2011	58
23704251	107869	Wang K	Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.	Circulation	2013	36
24516168	107869	King AL	Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent.	Proceedings of the National Academy of Sciences of the United States of America	2014	68
10101144	110006	Pan MH	Biotransformation of curcumin through reduction and glucuronidation in mice.	Drug metabolism and disposition	1999	123
24634822	110006	Mokadem M	Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency.	Molecular metabolism	2014	37
20648554	116939	Chen W	Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease.	Hepatology	2010	51
21068004	116939	Basantani MK	Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome.	Journal of lipid research	2011	50
22560221	116939	Kumari M	Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase.	Cell metabolism	2012	68
23023705	116939	Li JZ	Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.	The Journal of clinical investigation	2012	44
24917523	116939	Smagris E	Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis.	Hepatology	2015	41
15538359	238055	Soutschek J	Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.	Nature	2004	444
18060040	238055	Ota T	Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents.	The Journal of clinical investigation	2008	110
20615897	238055	Straarup EM	Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates.	Nucleic acids research	2010	51
